{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:21:33Z","timestamp":1790889693910,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,6,11]],"date-time":"2003-06-11T00:00:00Z","timestamp":1055289600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/1471-2261-3-5","type":"journal-article","created":{"date-parts":[[2003,7,9]],"date-time":"2003-07-09T06:23:09Z","timestamp":1057731789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Risk of valvular heart disease associated with use of fenfluramine"],"prefix":"10.1186","volume":"3","author":[{"given":"Paul N","family":"Hopkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald I","family":"Polukoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,6,11]]},"reference":[{"key":"27_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1056\/NEJM199708283370901","volume":"337","author":"HM Connolly","year":"1997","unstructured":"Connolly HM, Crary JL, McGoon M, Hensrud DD, Edwards BS, Edwards WD, Schaff HV: Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997, 337: 581-588. 10.1056\/NEJM199708283370901.","journal-title":"N Engl J Med"},{"key":"27_CR2","first-page":"1061","volume":"46","author":"R Bowen","year":"1997","unstructured":"Bowen R, Glicklich A, Khan M, Rasmussen S, Wadden T, Bilstad J, Graham D, Green L, Lumpkin M, O\u2019Neill R, Sobel S, Hubbard VS, Yanovski S, Sopko G: Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services Interim Public Health Recommendations. MMWR. 1997, 46: 1061-1066.","journal-title":"MMWR"},{"key":"27_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/j.1550-8528.1998.tb00350.x","volume":"6","author":"TA Wadden","year":"1998","unstructured":"Wadden TA, Berkowitz RI, Silvestry F, Vogt RA, St John Sutton MG, Stunkard AJ, Foster GD, Aber JL: The fen-phen finale: a study of weight loss and valvular heart disease. Obes Res. 1998, 6: 278-284.","journal-title":"Obes Res"},{"key":"27_CR4","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0002-9149(00)00840-7","volume":"86","author":"NE Lepor","year":"2000","unstructured":"Lepor NE, Gross SB, Daley WL, Samuels BA, Rizzo MJ, Luko SP, Hickey A, Buchbinder NA, Naqvi TZ: Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease. Am J Cardiol. 2000, 86: 107-110. 10.1016\/S0002-9149(00)00840-7.","journal-title":"Am J Cardiol"},{"key":"27_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/S0025-6196(11)64213-4","volume":"75","author":"CY Teramae","year":"2000","unstructured":"Teramae CY, Connolly HM, Grogan M, Miller F. A., Jr.: Diet drug-related cardiac valve disease: the Mayo Clinic echocardiographic laboratory experience. Mayo Clin Proc. 2000, 75: 456-461.","journal-title":"Mayo Clin Proc"},{"key":"27_CR6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S0735-1097(99)00321-6","volume":"34","author":"AJ Burger","year":"1999","unstructured":"Burger AJ, Sherman HB, Charlamb MJ, Kim J, Asinas LA, Flickner SR, Blackburn GL: Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months. J Am Coll Cardiol. 1999, 34: 1153-1158. 10.1016\/S0735-1097(99)00321-6.","journal-title":"J Am Coll Cardiol"},{"key":"27_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/NEJM199809103391101","volume":"339","author":"MA Khan","year":"1998","unstructured":"Khan MA, Herzog CA, St Peter JV, Hartley GG, Madlon-Kay R, Dick CD, Asinger RW, Vessey JT: The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs. N Engl J Med. 1998, 339: 713-718. 10.1056\/NEJM199809103391101.","journal-title":"N Engl J Med"},{"key":"27_CR8","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJM199809103391103","volume":"339","author":"NJ Weissman","year":"1998","unstructured":"Weissman NJ, Tighe J. F., Jr., Gottdiener JS, Gwynne JT: An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group. N Engl J Med. 1998, 339: 725-732. 10.1056\/NEJM199809103391103.","journal-title":"N Engl J Med"},{"key":"27_CR9","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1161\/01.CIR.100.21.2161","volume":"100","author":"BK Shively","year":"1999","unstructured":"Shively BK, Roldan CA, Gill EA, Najarian T, Loar SB: Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine. Circulation. 1999, 100: 2161-2167.","journal-title":"Circulation"},{"key":"27_CR10","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.4065\/74.12.1191","volume":"74","author":"DD Hensrud","year":"1999","unstructured":"Hensrud DD, Connolly HM, Grogan M, Miller FA, Bailey KR, Jensen MD: Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine. Mayo Clin Proc. 1999, 74: 1191-1197.","journal-title":"Mayo Clin Proc"},{"key":"27_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/j.1550-8528.1999.tb00414.x","volume":"7","author":"DH Ryan","year":"1999","unstructured":"Ryan DH, Bray GA, Helmcke F, Sander G, Volaufova J, Greenway F, Subramaniam P, Glancy DL: Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine. Obes Res. 1999, 7: 313-322.","journal-title":"Obes Res"},{"key":"27_CR12","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1001\/jama.283.13.1703","volume":"283","author":"JM Gardin","year":"2000","unstructured":"Gardin JM, Schumacher D, Constantine G, Davis KD, Leung C, Reid CL: Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine\/fenfluramine. JAMA. 2000, 283: 1703-1709. 10.1001\/jama.283.13.1703.","journal-title":"JAMA"},{"key":"27_CR13","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1161\/01.CIR.101.17.2071","volume":"101","author":"JG Jollis","year":"2000","unstructured":"Jollis JG, Landolfo CK, Kisslo J, Constantine GD, Davis KD, Ryan T: Fenfluramine and phentermine and cardiovascular findings: effect of treatment duration on prevalence of valve abnormalities. Circulation. 2000, 101: 2071-2077.","journal-title":"Circulation"},{"key":"27_CR14","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1001\/archinte.161.11.1429","volume":"161","author":"R Davidoff","year":"2001","unstructured":"Davidoff R, McTiernan A, Constantine G, Davis KD, Balady GJ, Mendes LA, Rudolph RE, Bowen DJ: Echocardiographic examination of women previously treated with fenfluramine: long-term follow-up of a randomized, double-blind, placebo-controlled trial. Arch Intern Med. 2001, 161: 1429-1436. 10.1001\/archinte.161.11.1429.","journal-title":"Arch Intern Med"},{"key":"27_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/S0002-9343(02)01123-3","volume":"112","author":"V Palmieri","year":"2002","unstructured":"Palmieri V, Arnett DK, Roman MJ, Liu JE, Bella JN, Oberman A, Kitzman DW, Hopkins PN, Morgan D, de Simone G, Devereux RB: Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study. Am J Med. 2002, 112: 710-715. 10.1016\/S0002-9343(02)01123-3.","journal-title":"Am J Med"},{"key":"27_CR16","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1056\/NEJM199809103391102","volume":"339","author":"H Jick","year":"1998","unstructured":"Jick H, Vasilakis C, Weinrauch LA, Meier CR, Jick SS, Derby LE: A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation. N Engl J Med. 1998, 339: 719-724. 10.1056\/NEJM199809103391102.","journal-title":"N Engl J Med"},{"key":"27_CR17","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00000441-200104000-00008","volume":"321","author":"NJ Weissman","year":"2001","unstructured":"Weissman NJ: Appetite suppressants and valvular heart disease. Am J Med Sci. 2001, 321: 285-291. 10.1097\/00000441-200104000-00008.","journal-title":"Am J Med Sci"},{"key":"27_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1472-6904-2-6","volume":"2","author":"YK Loke","year":"2002","unstructured":"Loke YK, Derry S, Pritchard-Copley A: Appetite suppressants and valvular heart disease - a systematic review. BMC Clin Pharmacol. 2002, 2: 6-10.1186\/1472-6904-2-6.","journal-title":"BMC Clin Pharmacol"},{"key":"27_CR19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/00001573-200209000-00007","volume":"17","author":"FF Seghatol","year":"2002","unstructured":"Seghatol FF, Rigolin VH: Appetite suppressants and valvular heart disease. Curr Opin Cardiol. 2002, 17: 486-492. 10.1097\/00001573-200209000-00007.","journal-title":"Curr Opin Cardiol"},{"key":"27_CR20","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1067\/mhj.2002.126733","volume":"144","author":"M Sachdev","year":"2002","unstructured":"Sachdev M, Miller WC, Ryan T, Jollis JG: Effect of fenfluramine-derivative diet pills on cardiac valves: a meta-analysis of observational studies. Am Heart J. 2002, 144: 1065-1073. 10.1067\/mhj.2002.126733.","journal-title":"Am Heart J"},{"key":"27_CR21","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0735-1097(99)00315-0","volume":"34","author":"NB Schiller","year":"1999","unstructured":"Schiller NB: Fen\/phen and valvular heart disease: if it sounds too bad to be true, perhaps it isn't. J Am Coll Cardiol. 1999, 34: 1159-1162. 10.1016\/S0735-1097(99)00315-0.","journal-title":"J Am Coll Cardiol"},{"key":"27_CR22","first-page":"478","volume":"340","author":"MA Khan","year":"1999","unstructured":"Khan MA, St. Peter JV, Herzog CA: Appetite-suppressant drugs and valvular heart disease [letter]. N Engl J Med. 1999, 340: 478-","journal-title":"N Engl J Med"},{"key":"27_CR23","doi-asserted-by":"publisher","first-page":"870","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00005","volume":"129","author":"CC Wee","year":"1998","unstructured":"Wee CC, Phillips RS, Aurigemma G, Erban S, Kriegel G, Riley M, Douglas PS: Risk for valvular heart disease among users of fenfluramine and dexfenfluramine who underwent echocardiography before use of medication. Ann Intern Med. 1998, 129: 870-874.","journal-title":"Ann Intern Med"},{"key":"27_CR24","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1001\/jama.286.16.2011","volume":"286","author":"JM Gardin","year":"2001","unstructured":"Gardin JM, Weissman NJ, Leung C, Panza JA, Fernicola D, Davis KD, Constantine GD, Reid CL: Clinical and echocardiographic follow-up of patients previously treated with dexfenfluramine or phentermine\/fenfluramine. JAMA. 2001, 286: 2011-2014. 10.1001\/jama.286.16.2011.","journal-title":"JAMA"},{"key":"27_CR25","doi-asserted-by":"publisher","first-page":"267","DOI":"10.7326\/0003-4819-134-4-200102200-00009","volume":"134","author":"NJ Weissman","year":"2001","unstructured":"Weissman NJ, Panza JA, Tighe JF, Gwynne JT: Natural history of valvular regurgitation 1 year after discontinuation of dexfenfluramine therapy. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2001, 134: 267-273.","journal-title":"Ann Intern Med"},{"key":"27_CR26","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0002-9149(98)01064-9","volume":"83","author":"JP Singh","year":"1999","unstructured":"Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, Lehman B, Benjamin EJ: Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999, 83: 897-902. 10.1016\/S0002-9149(98)01064-9.","journal-title":"Am J Cardiol"},{"key":"27_CR27","first-page":"I","volume":"90 (suppl I)","author":"CL Reid","year":"1994","unstructured":"Reid CL, Gardin JM, Yunis C, T. Kurosaki, Flack JM: Prevalence and clinical correlates of aortic and mitral regurgitation in a young adult population: The CARDIA Study [abstract]. Circulation. 1994, 90 (suppl I): I-282.","journal-title":"Circulation"},{"key":"27_CR28","volume-title":"Statistical Methods for Rates and Proportions","author":"JL Fleiss","year":"1981","unstructured":"Fleiss JL: Statistical Methods for Rates and Proportions. 1981, New York, John Wiley & Sons, Second","edition":"Second"},{"key":"27_CR29","volume-title":"Epidemiologic Research. Principles and Quantitative Methods.","author":"DG Kleinbaum","year":"1982","unstructured":"Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research. Principles and Quantitative Methods. 1982, New York, Van Nostrand Reinhold Company, Inc."},{"key":"27_CR30","doi-asserted-by":"publisher","first-page":"282","DOI":"10.7326\/0003-4819-134-4-200102200-00011","volume":"134","author":"LK Khan","year":"2001","unstructured":"Khan LK, Serdula MK, Bowman BA, Williamson DF: Use of prescription weight loss pills among U.S. adults in 1996-1998. Ann Intern Med. 2001, 134: 282-286.","journal-title":"Ann Intern Med"},{"key":"27_CR31","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/S0735-1097(00)00835-4","volume":"36","author":"LA Moye","year":"2000","unstructured":"Moye LA, Annegers AF: Underestimation of the valvulopathy effect of fenfluramine. J Am Coll Cardiol. 2000, 36: 1434-1436. 10.1016\/S0735-1097(00)00835-4.","journal-title":"J Am Coll Cardiol"},{"key":"27_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.7326\/0003-4819-134-4-200102200-00008","volume":"134","author":"ST Mast","year":"2001","unstructured":"Mast ST, Jollis JG, Ryan T, Anstrom KJ, Crary JL: The progression of fenfluramine-associated valvular heart disease assessed by echocardiography. Ann Intern Med. 2001, 134: 261-266.","journal-title":"Ann Intern Med"},{"key":"27_CR33","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.5858\/2001-125-1555-AAMFPV","volume":"125","author":"KE Volmar","year":"2001","unstructured":"Volmar KE, Hutchins GM: Aortic and mitral fenfluramine-phentermine valvulopathy in 64 patients treated with anorectic agents. Arch Pathol Lab Med. 2001, 125: 1555-1561.","journal-title":"Arch Pathol Lab Med"},{"key":"27_CR34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/01.CIR.103.3.401","volume":"103","author":"LM Voss","year":"2001","unstructured":"Voss LM, Wilson NJ, Neutze JM, Whitlock RM, Ameratunga RV, Cairns LM, Lennon DR: Intravenous immunoglobulin in acute rheumatic fever: a randomized controlled trial. Circulation. 2001, 103: 401-406.","journal-title":"Circulation"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-3-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-3-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-3-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-3-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:22:34Z","timestamp":1726244554000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-3-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6,11]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,12]]}},"alternative-id":["27"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-3-5","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6,11]]},"assertion":[{"value":"24 January 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"5"}}